NBD-F
CAS No. 29270-56-2
NBD-F ( 4-Fluoro-7-nitrobenzofurazan )
产品货号. M27038 CAS No. 29270-56-2
NBD-F is a fluorescent derivatization compound for amino acid analysis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥510 | 有现货 |
|
50MG | ¥721 | 有现货 |
|
100MG | ¥1158 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NBD-F
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NBD-F is a fluorescent derivatization compound for amino acid analysis.
-
产品描述NBD-F is a fluorescent derivatization compound for amino acid analysis.(In Vitro):As the percentage of the organic phase changes, the retention time of NBD-F remains relatively stable, while the retention times of the derivatization products change. The pH of the mobile phase affects the separation of the NBD-F and the derivatization products . NBD-F was recently applied to the analysis of other amino acid derivatives such as N-methyl-D-aspartic acid and glutathione. The use of NBD-F appears to have several advantages in that the derivatization procedure is simple and its derivatives are highly stable .
-
同义词4-Fluoro-7-nitrobenzofurazan
-
通路Others
-
靶点Other Targets
-
受体CMV; HIV
-
研究领域——
-
适应症——
化学信息
-
CAS Number29270-56-2
-
分子量183.1
-
分子式C6H2FN3O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[O-][N+](=O)c1ccc(F)c2nonc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Naesens L, et al. 9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo. Eur J Clin Microbiol Infect Dis. 1989;8(12):1043-1047.
产品手册
关联产品
-
Eculizumab
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
2,5-Morpholinedione,...
2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)- is the trans structure of Lateritin.